The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases [electronic resource]
Producer: 20190618Description: 661-674 p. digitalISSN:- 1303-6165
- Apoptosis
- Cell Line, Tumor
- Computer Simulation
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Janus Kinase 1
- Janus Kinase 2
- Janus Kinase Inhibitors -- adverse effects
- Lymphoproliferative Disorders -- chemically induced
- Nitriles
- Pyrazoles -- adverse effects
- Pyrimidines
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.